StomaCare: Quality of Life Impact After Enhanced Follow-up of Ostomy Patients

Sponsor
FSK (Industry)
Overall Status
Not yet recruiting
CT.gov ID
NCT05076669
Collaborator
(none)
350
10
2
26
35
1.3

Study Details

Study Description

Brief Summary

In this context, FSK would like to implement a clinical study to assess the added value on the health-related QoL from the enhanced follow-up of ostomy patients by a HHN including stomal therapists.

The interventional group will benefit from delivery and enhanced follow-up by the FSK HHN provided, in particular, by stomal therapy nurse consultants and patient-relation experts during in-person or remote appointments in addition to the routine care delivered and prescribed by the sites.

The control group will receive the routine care prescribed by the sites and will be provided with ostomy equipment by FSK.

Condition or Disease Intervention/Treatment Phase
  • Other: stoma follow-up
  • Other: standard of care
N/A

Detailed Description

France currently has about 80,000 ostomy patients. Stoma placement exposes patients to many surgical or peristomal skin complications which could impair the quality of life of the ostomy patient.

The management of ostomy patients varies from institution to institution and according to how the patient's medical equipment is supplied as well as whether or not specialised personnel are available.

In the last decade, the market for stoma therapy in France has evolved, with a significant increase in the delivery of equipment by HHNs, meeting a need for patient follow-up and accompaniment.

This increased preference of HHNs to use specialist nurses seems to be explained by the added benefits. Early international studies have demonstrated the impact of an enterostomal therapy nurse follow-up on the improvement of ostomy patient's quality of life (QoL) relative to their health.

However, none of the studies available today on follow-ups performed by an enterostomal therapist included the French population. Furthermore, the studies show methodological gaps, a limited time span and are based on strong hypotheses.

In this context, FSK would like to implement a clinical study to assess the added value on the health-related QoL from the enhanced follow-up of ostomy patients by a HHN including stomal therapists.

The interventional group will benefit from delivery and enhanced follow-up by the FSK HHN provided, in particular, by stomal therapy nurse consultants and patient-relation experts during in-person or remote appointments in addition to the routine care delivered and prescribed by the sites.

The control group will receive the routine care prescribed by the sites and will be provided with ostomy equipment by FSK.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
350 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Open-label, randomised, comparative, controlled, national and multi-centre study with minimal risks and constraints to routine care.Open-label, randomised, comparative, controlled, national and multi-centre study with minimal risks and constraints to routine care.
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Quality of Life Impact After Enhanced Follow-up of Ostomy Patients by a Home Healthcare Nursing Service Employing Stomal Therapy Nurse Consultants Compared to Conventional Care
Anticipated Study Start Date :
Oct 1, 2021
Anticipated Primary Completion Date :
Aug 1, 2023
Anticipated Study Completion Date :
Dec 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Control

The control group will receive the routine care prescribed by the sites and will be provided with ostomy equipment by FSK.

Other: standard of care
routine management of stoma

Experimental: interventional group

The interventional group will benefit from delivery and enhanced follow-up by the FSK HHN provided, in particular, by stomal therapy nurse consultants and patient-relation experts during in-person or remote appointments in addition to the routine care delivered and prescribed by the sites.

Other: stoma follow-up
delivery and enhanced follow-up by the FSK HHN provided, in particular, by stomal therapy nurse consultants and patient-relation experts during in-person or remote appointments in addition to the routine care delivered and prescribed by the sites

Outcome Measures

Primary Outcome Measures

  1. Efficacy [3 months]

    score from the Stoma-QOL specific questionnaire (min: 0- max: 100), analysis of the mean

Secondary Outcome Measures

  1. Satisfaction of patient [3 and 6 months]

    scale 0-100

  2. Quality of life [1, 2, 3 and 6 months]

    Stoma-QOL questionnaire, (min: 0- max: 100), analysis of the mean

  3. Quality of life [1, 2, 3 and 6 months]

    EQ-5D-5L questionnaire (min: 0- max: 1), analysis of the mean

  4. Cost [3 and 6 months]

    • Calculation of resource use at 3 and 6 months per expenditure item (use of services, drug use, medical device and home healthcare service use, MCO (Médecine chirurgie obstétrique [Obstetric surgery]) hospitalisations and SSR (Soins de suite et de réadaptation [Follow-up care and rehabilitation]) hospitalisations) for each group.

  5. Morbidity [3 and 6 months]

    readmission rate

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Male or female ≥ 18 years

  • Patients with a stoma placed less than 10 days ago

  • Patients who had a stoma during their current hospitalisation

  • Patients informed verbally and in writing via the information sheet and who signed the informed consent form.

Exclusion Criteria:
  • Patients in palliative care

  • Patients participating in another clinical study interested in the management of ostomy patients

  • Patients not enrolled in a social security system or with the CMU (Couverture maladie universelle [Universal Health Coverage])

  • Patients under judicial protection or under guardianship

  • Patients deprived of freedom (in prison and psychiatric patients being treated without consent)

  • Patients with difficulties understanding or reading French

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hopital Bicètre Le Kremlin-Bicêtre France 93043
2 Hopital Lyon-Sud Lyon France
3 Hopital SAint Louis Paris France 75009
4 Hopital Saint-Louis Paris France 75009
5 Hopital Saint-Antoine Paris France 75012
6 Hopital de la Pitié-Salpétrière Paris France 75013
7 Hopital HEGP Paris France 75015
8 ESPIC FOCH - Digestige Unit Suresnes France
9 ESPIC Foch - Urology Unit Suresnes France
10 CHU Toulouse Toulouse France

Sponsors and Collaborators

  • FSK

Investigators

  • Principal Investigator: Jeremie H Lefevre, MD, PhD, Sorbonne University

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

Responsible Party:
FSK
ClinicalTrials.gov Identifier:
NCT05076669
Other Study ID Numbers:
  • FSK-001
  • NCT05061927
First Posted:
Oct 13, 2021
Last Update Posted:
Oct 13, 2021
Last Verified:
Sep 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Oct 13, 2021